[Featured Stock] Nivec Hits Upper Limit on Contract News with 6 Multinational Pharmaceutical Companies
[Asia Economy Reporter Kum Bo-ryeong] Naivek recorded the daily upper limit on the 21st following news that it signed material supply agreements with six multinational pharmaceutical companies at the world's largest international bio-healthcare conference.
According to the Korea Exchange, as of 3:14 PM that day, Naivek was trading at 13,150 KRW, up 29.56% (3,000 KRW) from the previous day.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
At the 'JP Morgan Healthcare Conference,' Naivek signed material transfer agreements (MTA) and confidentiality agreements (CDA) with six multinational pharmaceutical companies regarding its anticancer drug and peptide platform (NIPEP-TPP) applied to anticancer treatment.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
